Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity

Image 1Dr. Pengcheng Zhou completed his PhD study in immunology with Professor. Di Yu, Professor. Carola G. Vinuesa and Professor. Scott N. Mueller at the John Curtin School of Medical Research, the Australian National University (ANU) in 2020. Dr. Zhou’s major research focus are T cell and B cell immunity in regulating germinal center response and development of novel cytokine-based therapy in autoimmune and infectious diseases. Dr. Zhou’s research led to 12 research articles in journals including Journal of Clinical Investigation, Science Immunology, PLoS Pathogens, Environmental Science & Technology and Frontiers in Immunology with him as the senior corresponding author or 1st author. Dr. Zhou serves as the reviewer for journals including Journal of Clinical Investigation and JCI insight since 2020, and the editorial board member of Frontiers in Endocrinology.

© 2022 The Author(s). Published by Elsevier Ltd.

留言 (0)

沒有登入
gif